Nasser, Samar A.
Pender, Ashley
Ali, Ayan
Tobb, Kardie
Ferdinand, Keith C.
Article History
Received: 27 February 2025
Accepted: 27 August 2025
First Online: 27 January 2026
Declarations
:
: Dr. Ferdinand reports consulting fees from Boehringer Ingelheim, Amgen, Novartis, Medtronic, Janssen, and Lilly, outside the submitted work. The other authors declare that they have no conflict of interest.
: No animal or human subjects by the authors were used in this manuscript.